Related Experiment Video
Updated: Aug 9, 2026

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
Published on: March 1, 2020
Check, double check: the G2 barrier to cancer
1Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Abstract:
Loss of the G1/S checkpoint is recognized as a mandatory step in the development of cancer. Nevertheless, both in vivo and in vitro experiments have indicated that this condition highly sensitizes cells to apoptosis, e.g., primary mouse embryonic fibroblasts that lack the complete retinoblastoma suppressor gene family (TKO MEFs) massively die under mitogen-deprived conditions. The prevailing hypothesis therefore is that the increased proliferative capacity of cells that have lost the G1/S checkpoint becomes apparent by suppression of apoptosis. However, this view was recently challenged by the finding that suppression of apoptotic cell death in TKO MEFs did not allow unconstrained proliferation; instead, cells became arrested in G2. This mechanism, which is dependent on p53, provides yet another barrier to oncogenic transformation. Thus, progression to malignancy of Rb-deficient lesions by alleviation of G2 arrest may offer an alternative explanation for the synergism between loss of Rb and p53 in tumorigenesis.
Insights
Loss of the G1/S checkpoint, critical for cancer, sensitizes cells to apoptosis. Suppressing this cell death leads to G2 arrest, not proliferation, revealing a new barrier to tumor development.
Area of Science:
- Cellular biology
- Cancer research
- Molecular oncology
Background:
- Loss of the G1/S cell cycle checkpoint is a key event in cancer development.
- Cells lacking retinoblastoma tumor suppressor genes (TKO MEFs) undergo apoptosis under specific conditions.
- This apoptosis is considered a barrier to uncontrolled cell proliferation.
Purpose of the Study:
- To investigate the consequences of suppressing apoptosis in cells lacking the G1/S checkpoint.
- To explore the role of p53 and G2 arrest in preventing oncogenic transformation.
- To re-evaluate the hypothesis linking G1/S checkpoint loss to cancer progression via apoptosis suppression.
Main Methods:
- Utilized primary mouse embryonic fibroblasts lacking the retinoblastoma suppressor gene family (TKO MEFs).
- Experimentally suppressed apoptotic cell death in these cells.
- Analyzed cell cycle progression, focusing on G1/S and G2 checkpoints.
- Investigated the role of p53 in mediating cellular responses.
Main Results:
- Suppression of apoptosis in TKO MEFs did not result in unconstrained proliferation.
- Instead, cells lacking both G1/S checkpoint and apoptosis control arrested in the G2 phase.
- This G2 arrest was dependent on the p53 tumor suppressor protein.
- Alleviation of G2 arrest is proposed as a potential mechanism for tumorigenesis in Rb-deficient cells.
Conclusions:
- The loss of the G1/S checkpoint alone does not guarantee proliferation due to a p53-dependent G2 arrest.
- This G2 checkpoint acts as a significant barrier against oncogenic transformation.
- The interplay between Rb deficiency, apoptosis suppression, and p53-mediated G2 arrest is crucial in cancer development.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
